Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6621
|
pubmed:dateCreated |
1997-4-3
|
pubmed:abstractText |
Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1). Three naturally occurring ligands for the IL-1 receptor (IL1R) exist: the agonists IL-1alpha and IL-1beta and the IL-1-receptor antagonist IL1RA (ref. 2). IL-1 is the only cytokine for which a naturally occurring antagonist is known. Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of type-I IL1R complexed with IL1RA. The receptor consists of three immunoglobulin-like domains. Domains 1 and 2 are tightly linked, but domain three is completely separate and connected by a flexible linker. Residues of all three domains contact the antagonist and include the five critical IL1RA residues which were identified by site-directed mutagenesis. A region that is important for biological function in IL-1beta, the 'receptor trigger site' is not in direct contact with the receptor in the IL1RA complex. Modelling studies suggest that this IL-1beta trigger site might induce a movement of domain 3.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Il1rn protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
386
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-200
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9062194-Amino Acid Sequence,
pubmed-meshheading:9062194-Animals,
pubmed-meshheading:9062194-CHO Cells,
pubmed-meshheading:9062194-Cricetinae,
pubmed-meshheading:9062194-Crystallography, X-Ray,
pubmed-meshheading:9062194-Humans,
pubmed-meshheading:9062194-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:9062194-Mice,
pubmed-meshheading:9062194-Models, Molecular,
pubmed-meshheading:9062194-Molecular Sequence Data,
pubmed-meshheading:9062194-Protein Binding,
pubmed-meshheading:9062194-Protein Conformation,
pubmed-meshheading:9062194-Protein Folding,
pubmed-meshheading:9062194-Receptors, Interleukin-1,
pubmed-meshheading:9062194-Recombinant Proteins,
pubmed-meshheading:9062194-Sequence Alignment,
pubmed-meshheading:9062194-Sialoglycoproteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
|
pubmed:affiliation |
Marion Merrell Dow Research Institute, Strasbourg, France.
|
pubmed:publicationType |
Journal Article
|